全文获取类型
收费全文 | 91842篇 |
免费 | 45300篇 |
国内免费 | 220篇 |
专业分类
耳鼻咽喉 | 1744篇 |
儿科学 | 4912篇 |
妇产科学 | 1100篇 |
基础医学 | 17898篇 |
口腔科学 | 5381篇 |
临床医学 | 13660篇 |
内科学 | 26458篇 |
皮肤病学 | 7743篇 |
神经病学 | 14531篇 |
特种医学 | 2717篇 |
外国民族医学 | 1篇 |
外科学 | 16112篇 |
综合类 | 475篇 |
一般理论 | 45篇 |
预防医学 | 6958篇 |
眼科学 | 1713篇 |
药学 | 6502篇 |
2篇 | |
中国医学 | 1142篇 |
肿瘤学 | 8268篇 |
出版年
2023年 | 203篇 |
2022年 | 117篇 |
2021年 | 1864篇 |
2020年 | 5269篇 |
2019年 | 11227篇 |
2018年 | 10614篇 |
2017年 | 11800篇 |
2016年 | 12473篇 |
2015年 | 12365篇 |
2014年 | 12442篇 |
2013年 | 13177篇 |
2012年 | 5506篇 |
2011年 | 5481篇 |
2010年 | 9760篇 |
2009年 | 5954篇 |
2008年 | 3154篇 |
2007年 | 2090篇 |
2006年 | 2079篇 |
2005年 | 1670篇 |
2004年 | 1625篇 |
2003年 | 1597篇 |
2002年 | 1567篇 |
2001年 | 1109篇 |
2000年 | 992篇 |
1999年 | 521篇 |
1998年 | 148篇 |
1997年 | 137篇 |
1996年 | 126篇 |
1995年 | 103篇 |
1994年 | 104篇 |
1993年 | 74篇 |
1992年 | 188篇 |
1991年 | 165篇 |
1990年 | 184篇 |
1989年 | 191篇 |
1988年 | 160篇 |
1987年 | 151篇 |
1986年 | 128篇 |
1985年 | 115篇 |
1984年 | 91篇 |
1983年 | 78篇 |
1982年 | 41篇 |
1981年 | 40篇 |
1980年 | 46篇 |
1979年 | 51篇 |
1978年 | 27篇 |
1977年 | 31篇 |
1975年 | 30篇 |
1974年 | 25篇 |
1973年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
11.
Jean‐Franois Etter 《Addiction (Abingdon, England)》2019,114(12):2252-2256
12.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献
13.
14.
15.
16.
17.
Anne E. Kazak Fang Fang Chen Wei‐Ting Hwang Martha A. Askins Gabriela Vega E. Anders Kolb Anne Reilly Lamia P. Barakat 《Pediatric blood & cancer》2020,67(2)
Purpose: Family psychosocial risk in pediatric oncology can be assessed using the Psychosocial Assessment Tool (PAT), a brief parent report screener based on the Pediatric Psychosocial Preventative Health Model (PPPHM; universal, targeted, and clinical). However, little is known about risk over the course of treatment and its association with medical and psychosocial healthcare utilization. Methods: Primary caregivers of children with cancer participated in this prospective multisite investigation, completing the PAT at diagnosis (T1; n = 396) and 6 months later (T2; n = 304). Healthcare utilization data were extracted from electronic health records. Results: The distribution of PPPHM risk levels at T1 and T2 was highly consistent for the samples. Two‐thirds of families remained at the same level of risk, 18% decreased and 16% increased risk level. Risk was not related to sociodemographic or treatment variables. The PAT risk score correlated with psychosocial contacts over the 6‐month period. Conclusions: Although the majority of families reported universal (low) risk on the PAT and were stable in their risk level over 6 months, reassessing risk is helpful in identifying those families who report higher level of risk during treatment than at diagnosis. PAT scores were related to psychosocial services that are provided to most but not all families and could be tailored more specifically to match risk and delivery of evidence‐based care. 相似文献
18.
Ángel Becerra Héctor Trujillo Lucía Valencia Aurelio Rodríguez‐Pérez 《Brazilian Journal of Anesthesiology》2019,69(2):200-203
Background and objectives
A prompt and effective management of trauma patient is necessary. The aim of this case report is to highlight the importance of intraoperative echocardiography as a useful tool in patients suffering from refractory hemodynamic instability no otherwise explained.Case report
A 41 year‐old woman suffered a car accident. At the emergency department, no abnormalities were found in ECG or chest X‐ray. Abdominal ultrasound revealed the presence of abdominal free liquid and the patient was submitted to urgent exploratory laparotomy. Nevertheless, she persisted suffering arterial hypotension and metabolic acidosis. Looking for the reason of her hemodynamic instability, intraoperative transthoracic echocardiography was performed, finding out the presence of pericardial effusion. Once the cardiac surgeon extracted pericardial clots, patient's situation improved clinically and analytically.Conclusion
Every anesthesiologist should be able to use the intraoperative echocardiography as an effective tool in order to establish the appropriate measures to promote the survival of patients suffering severe trauma. 相似文献19.